The pathophysiology of osteoarthritis

被引:238
作者
Iannone, F [1 ]
Lapadula, G [1 ]
机构
[1] Univ Bari, Dipartimento Med Interna & Med Pubbl, Sezione Reumatol, Div Rheumatol,DIMIMP, I-70124 Bari, Italy
关键词
articular cartilage; chondrocytes; cytokines; growth factors; metalloproteinases; osteoarthritis; OA pathophysiology;
D O I
10.1007/BF03327357
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 [法学]; 0303 [社会学]; 100203 [老年医学];
摘要
Osteoarthritis (OA) is a complex disease whose pathogenesis includes the contribution of biomechanical and metabolic factors which, altering the tissue homeostasis of articular cartilage and subchondral bone, determine the predominance of destructive over productive processes. A key role in the pathophysiology of articular cartilage is played by cell/extra-cellular matrix (ECM) interactions, which are mediated by cell surface integrins. In a physiologic setting, integrins modulate cell/ECM signaling, essential for regulating growth and differentiation and maintaining cartilage homeostasis. During CIA, abnormal integrin expression alters cell/ECM signaling and modifies chondrocyte synthesis, with the following imbalance of destructive cytokines over regulatory factors. IL-1, TNF-alpha and other pro-catabolic cytokines activate the enzymatic degradation of cartilage matrix and are not counterbalanced by adequate synthesis of inhibitors. The main enzymes involved in ECM breakdown are metalloproteinases (MMPs), which are sequentially activated by an amplifying cascade. MMP activity is partially inhibited by the tissue inhibitors of MMPs (TIMPs), whose synthesis is low compared with MMP production in OA cartilage. Intriguing is the role of growth factors such as TGF-beta, IFG, BMP, NGF, and others, which do not simply repair the tissue damage induced by catabolic factors, but play an important role in OA pathogenesis.
引用
收藏
页码:364 / 372
页数:9
相关论文
共 91 条
[1]
ADAMS ME, 1991, J RHEUMATOL, V18, P428
[2]
Apoptosis and cellular vitality - Issues in osteoarthritic cartilage degeneration [J].
Aigner, T ;
Kim, HA .
ARTHRITIS AND RHEUMATISM, 2002, 46 (08) :1986-1996
[3]
Alaaeddine N, 1997, J RHEUMATOL, V24, P1985
[4]
Amin Ashok R., 1998, Current Opinion in Rheumatology, V10, P263, DOI 10.1097/00002281-199805000-00018
[5]
INTERLEUKIN-1 RECEPTOR ANTAGONIST [J].
AREND, WP .
ADVANCES IN IMMUNOLOGY, VOL 54, 1993, 54 :167-227
[6]
Interleukin-17 up-regulation of nitric oxide production in human osteoarthritis cartilage [J].
Attur, MG ;
Patel, RN ;
Abramson, SB ;
Amin, AR .
ARTHRITIS AND RHEUMATISM, 1997, 40 (06) :1050-1053
[7]
BRANDT KD, 1991, J RHEUMATOL, V18, P436
[8]
Cantatore FP, 2001, J RHEUMATOL, V28, P922
[9]
β1-Integrin-collagen interaction reduces chondrocyte apoptosis [J].
Cao, L ;
Lee, V ;
Adams, ME ;
Kiani, C ;
Zhang, YO ;
Hu, W ;
Yang, BB .
MATRIX BIOLOGY, 1999, 18 (04) :343-355
[10]
Chondroprotective effect of intraarticular injections of interleukin-1 receptor antagonist in experimental osteoarthritis - Suppression of collagenase-1 expression [J].
Caron, JP ;
Fernandes, JC ;
MartellPelletier, J ;
Tardif, G ;
Mineau, F ;
Geng, CS ;
Pelletier, JP .
ARTHRITIS AND RHEUMATISM, 1996, 39 (09) :1535-1544